Oligonucleotide Synthesis-United States Market Status and Trend Report 2013-2023
![](/report_cover/10724/oligonucleotide-synthesis-united-states-market-status-n-trend-report-2013-2023_en.gif)
Report Summary
Oligonucleotide Synthesis-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Oligonucleotide Synthesis industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Oligonucleotide Synthesis 2013-2017, and development forecast 2018-2023
Main market players of Oligonucleotide Synthesis in United States, with company and product introduction, position in the Oligonucleotide Synthesis market
Market status and development trend of Oligonucleotide Synthesis by types and applications
Cost and profit status of Oligonucleotide Synthesis, and marketing status
Market growth drivers and challenges
The report segments the United States Oligonucleotide Synthesis market as:
United States Oligonucleotide Synthesis Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Oligonucleotide Synthesis Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Primer
Probe
Reagent
United States Oligonucleotide Synthesis Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Academic
Pharmaceutical
Biotechnology
United States Oligonucleotide Synthesis Market: Players Segment Analysis (Company and Product introduction, Oligonucleotide Synthesis Sales Volume, Revenue, Price and Gross Margin):
INTEGRATED DNA TECHNOLOGIES, INC.
MERCK KGAA
EUROFINS GENOMICS
THERMO FISHER SCIENTIFIC INC.
BIOAUTOMATION CORPORATION
AGILENT TECHNOLOGIES, INC.
EUROGENTEC S.A.
GENERAL ELECTRIC (GE) COMPANY
LGC BIOSEARCH TECHNOLOGIES, INC.
NITTO DENKO AVECIA INC.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Oligonucleotide Synthesis-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Oligonucleotide Synthesis industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Oligonucleotide Synthesis 2013-2017, and development forecast 2018-2023
Main market players of Oligonucleotide Synthesis in United States, with company and product introduction, position in the Oligonucleotide Synthesis market
Market status and development trend of Oligonucleotide Synthesis by types and applications
Cost and profit status of Oligonucleotide Synthesis, and marketing status
Market growth drivers and challenges
The report segments the United States Oligonucleotide Synthesis market as:
United States Oligonucleotide Synthesis Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Oligonucleotide Synthesis Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Primer
Probe
Reagent
United States Oligonucleotide Synthesis Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Academic
Pharmaceutical
Biotechnology
United States Oligonucleotide Synthesis Market: Players Segment Analysis (Company and Product introduction, Oligonucleotide Synthesis Sales Volume, Revenue, Price and Gross Margin):
INTEGRATED DNA TECHNOLOGIES, INC.
MERCK KGAA
EUROFINS GENOMICS
THERMO FISHER SCIENTIFIC INC.
BIOAUTOMATION CORPORATION
AGILENT TECHNOLOGIES, INC.
EUROGENTEC S.A.
GENERAL ELECTRIC (GE) COMPANY
LGC BIOSEARCH TECHNOLOGIES, INC.
NITTO DENKO AVECIA INC.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF OLIGONUCLEOTIDE SYNTHESIS
1.1 Definition of Oligonucleotide Synthesis in This Report
1.2 Commercial Types of Oligonucleotide Synthesis
1.2.1 Primer
1.2.2 Probe
1.2.3 Reagent
1.3 Downstream Application of Oligonucleotide Synthesis
1.3.1 Academic
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.4 Development History of Oligonucleotide Synthesis
1.5 Market Status and Trend of Oligonucleotide Synthesis 2013-2023
1.5.1 United States Oligonucleotide Synthesis Market Status and Trend 2013-2023
1.5.2 Regional Oligonucleotide Synthesis Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Oligonucleotide Synthesis in United States 2013-2017
2.2 Consumption Market of Oligonucleotide Synthesis in United States by Regions
2.2.1 Consumption Volume of Oligonucleotide Synthesis in United States by Regions
2.2.2 Revenue of Oligonucleotide Synthesis in United States by Regions
2.3 Market Analysis of Oligonucleotide Synthesis in United States by Regions
2.3.1 Market Analysis of Oligonucleotide Synthesis in New England 2013-2017
2.3.2 Market Analysis of Oligonucleotide Synthesis in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Oligonucleotide Synthesis in The Midwest 2013-2017
2.3.4 Market Analysis of Oligonucleotide Synthesis in The West 2013-2017
2.3.5 Market Analysis of Oligonucleotide Synthesis in The South 2013-2017
2.3.6 Market Analysis of Oligonucleotide Synthesis in Southwest 2013-2017
2.4 Market Development Forecast of Oligonucleotide Synthesis in United States 2018-2023
2.4.1 Market Development Forecast of Oligonucleotide Synthesis in United States 2018-2023
2.4.2 Market Development Forecast of Oligonucleotide Synthesis by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Oligonucleotide Synthesis in United States by Types
3.1.2 Revenue of Oligonucleotide Synthesis in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Oligonucleotide Synthesis in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Oligonucleotide Synthesis in United States by Downstream Industry
4.2 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in Major Countries
4.2.1 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in New England
4.2.2 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in The Midwest
4.2.4 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in The West
4.2.5 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in The South
4.2.6 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in Southwest
4.3 Market Forecast of Oligonucleotide Synthesis in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF OLIGONUCLEOTIDE SYNTHESIS
5.1 United States Economy Situation and Trend Overview
5.2 Oligonucleotide Synthesis Downstream Industry Situation and Trend Overview
CHAPTER 6 OLIGONUCLEOTIDE SYNTHESIS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Oligonucleotide Synthesis in United States by Major Players
6.2 Revenue of Oligonucleotide Synthesis in United States by Major Players
6.3 Basic Information of Oligonucleotide Synthesis by Major Players
6.3.1 Headquarters Location and Established Time of Oligonucleotide Synthesis Major Players
6.3.2 Employees and Revenue Level of Oligonucleotide Synthesis Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 OLIGONUCLEOTIDE SYNTHESIS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 INTEGRATED DNA TECHNOLOGIES, INC.
7.1.1 Company profile
7.1.2 Representative Oligonucleotide Synthesis Product
7.1.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of INTEGRATED DNA TECHNOLOGIES, INC.
7.2 MERCK KGAA
7.2.1 Company profile
7.2.2 Representative Oligonucleotide Synthesis Product
7.2.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of MERCK KGAA
7.3 EUROFINS GENOMICS
7.3.1 Company profile
7.3.2 Representative Oligonucleotide Synthesis Product
7.3.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of EUROFINS GENOMICS
7.4 THERMO FISHER SCIENTIFIC INC.
7.4.1 Company profile
7.4.2 Representative Oligonucleotide Synthesis Product
7.4.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of THERMO FISHER SCIENTIFIC INC.
7.5 BIOAUTOMATION CORPORATION
7.5.1 Company profile
7.5.2 Representative Oligonucleotide Synthesis Product
7.5.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of BIOAUTOMATION CORPORATION
7.6 AGILENT TECHNOLOGIES, INC.
7.6.1 Company profile
7.6.2 Representative Oligonucleotide Synthesis Product
7.6.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of AGILENT TECHNOLOGIES, INC.
7.7 EUROGENTEC S.A.
7.7.1 Company profile
7.7.2 Representative Oligonucleotide Synthesis Product
7.7.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of EUROGENTEC S.A.
7.8 GENERAL ELECTRIC (GE) COMPANY
7.8.1 Company profile
7.8.2 Representative Oligonucleotide Synthesis Product
7.8.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of GENERAL ELECTRIC (GE) COMPANY
7.9 LGC BIOSEARCH TECHNOLOGIES, INC.
7.9.1 Company profile
7.9.2 Representative Oligonucleotide Synthesis Product
7.9.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of LGC BIOSEARCH TECHNOLOGIES, INC.
7.10 NITTO DENKO AVECIA INC.
7.10.1 Company profile
7.10.2 Representative Oligonucleotide Synthesis Product
7.10.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of NITTO DENKO AVECIA INC.
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF OLIGONUCLEOTIDE SYNTHESIS
8.1 Industry Chain of Oligonucleotide Synthesis
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF OLIGONUCLEOTIDE SYNTHESIS
9.1 Cost Structure Analysis of Oligonucleotide Synthesis
9.2 Raw Materials Cost Analysis of Oligonucleotide Synthesis
9.3 Labor Cost Analysis of Oligonucleotide Synthesis
9.4 Manufacturing Expenses Analysis of Oligonucleotide Synthesis
CHAPTER 10 MARKETING STATUS ANALYSIS OF OLIGONUCLEOTIDE SYNTHESIS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Oligonucleotide Synthesis in This Report
1.2 Commercial Types of Oligonucleotide Synthesis
1.2.1 Primer
1.2.2 Probe
1.2.3 Reagent
1.3 Downstream Application of Oligonucleotide Synthesis
1.3.1 Academic
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.4 Development History of Oligonucleotide Synthesis
1.5 Market Status and Trend of Oligonucleotide Synthesis 2013-2023
1.5.1 United States Oligonucleotide Synthesis Market Status and Trend 2013-2023
1.5.2 Regional Oligonucleotide Synthesis Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Oligonucleotide Synthesis in United States 2013-2017
2.2 Consumption Market of Oligonucleotide Synthesis in United States by Regions
2.2.1 Consumption Volume of Oligonucleotide Synthesis in United States by Regions
2.2.2 Revenue of Oligonucleotide Synthesis in United States by Regions
2.3 Market Analysis of Oligonucleotide Synthesis in United States by Regions
2.3.1 Market Analysis of Oligonucleotide Synthesis in New England 2013-2017
2.3.2 Market Analysis of Oligonucleotide Synthesis in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Oligonucleotide Synthesis in The Midwest 2013-2017
2.3.4 Market Analysis of Oligonucleotide Synthesis in The West 2013-2017
2.3.5 Market Analysis of Oligonucleotide Synthesis in The South 2013-2017
2.3.6 Market Analysis of Oligonucleotide Synthesis in Southwest 2013-2017
2.4 Market Development Forecast of Oligonucleotide Synthesis in United States 2018-2023
2.4.1 Market Development Forecast of Oligonucleotide Synthesis in United States 2018-2023
2.4.2 Market Development Forecast of Oligonucleotide Synthesis by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Oligonucleotide Synthesis in United States by Types
3.1.2 Revenue of Oligonucleotide Synthesis in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Oligonucleotide Synthesis in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Oligonucleotide Synthesis in United States by Downstream Industry
4.2 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in Major Countries
4.2.1 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in New England
4.2.2 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in The Midwest
4.2.4 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in The West
4.2.5 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in The South
4.2.6 Demand Volume of Oligonucleotide Synthesis by Downstream Industry in Southwest
4.3 Market Forecast of Oligonucleotide Synthesis in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF OLIGONUCLEOTIDE SYNTHESIS
5.1 United States Economy Situation and Trend Overview
5.2 Oligonucleotide Synthesis Downstream Industry Situation and Trend Overview
CHAPTER 6 OLIGONUCLEOTIDE SYNTHESIS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Oligonucleotide Synthesis in United States by Major Players
6.2 Revenue of Oligonucleotide Synthesis in United States by Major Players
6.3 Basic Information of Oligonucleotide Synthesis by Major Players
6.3.1 Headquarters Location and Established Time of Oligonucleotide Synthesis Major Players
6.3.2 Employees and Revenue Level of Oligonucleotide Synthesis Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 OLIGONUCLEOTIDE SYNTHESIS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 INTEGRATED DNA TECHNOLOGIES, INC.
7.1.1 Company profile
7.1.2 Representative Oligonucleotide Synthesis Product
7.1.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of INTEGRATED DNA TECHNOLOGIES, INC.
7.2 MERCK KGAA
7.2.1 Company profile
7.2.2 Representative Oligonucleotide Synthesis Product
7.2.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of MERCK KGAA
7.3 EUROFINS GENOMICS
7.3.1 Company profile
7.3.2 Representative Oligonucleotide Synthesis Product
7.3.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of EUROFINS GENOMICS
7.4 THERMO FISHER SCIENTIFIC INC.
7.4.1 Company profile
7.4.2 Representative Oligonucleotide Synthesis Product
7.4.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of THERMO FISHER SCIENTIFIC INC.
7.5 BIOAUTOMATION CORPORATION
7.5.1 Company profile
7.5.2 Representative Oligonucleotide Synthesis Product
7.5.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of BIOAUTOMATION CORPORATION
7.6 AGILENT TECHNOLOGIES, INC.
7.6.1 Company profile
7.6.2 Representative Oligonucleotide Synthesis Product
7.6.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of AGILENT TECHNOLOGIES, INC.
7.7 EUROGENTEC S.A.
7.7.1 Company profile
7.7.2 Representative Oligonucleotide Synthesis Product
7.7.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of EUROGENTEC S.A.
7.8 GENERAL ELECTRIC (GE) COMPANY
7.8.1 Company profile
7.8.2 Representative Oligonucleotide Synthesis Product
7.8.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of GENERAL ELECTRIC (GE) COMPANY
7.9 LGC BIOSEARCH TECHNOLOGIES, INC.
7.9.1 Company profile
7.9.2 Representative Oligonucleotide Synthesis Product
7.9.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of LGC BIOSEARCH TECHNOLOGIES, INC.
7.10 NITTO DENKO AVECIA INC.
7.10.1 Company profile
7.10.2 Representative Oligonucleotide Synthesis Product
7.10.3 Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin of NITTO DENKO AVECIA INC.
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF OLIGONUCLEOTIDE SYNTHESIS
8.1 Industry Chain of Oligonucleotide Synthesis
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF OLIGONUCLEOTIDE SYNTHESIS
9.1 Cost Structure Analysis of Oligonucleotide Synthesis
9.2 Raw Materials Cost Analysis of Oligonucleotide Synthesis
9.3 Labor Cost Analysis of Oligonucleotide Synthesis
9.4 Manufacturing Expenses Analysis of Oligonucleotide Synthesis
CHAPTER 10 MARKETING STATUS ANALYSIS OF OLIGONUCLEOTIDE SYNTHESIS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference